Mylan Pharmaceuticals CEO Heather Bresch is
desperately trying to control the public relations disaster created by
her company’s decision to jack up the price of the life-saving EpiPen
drug by 450 percent.
***
The company just lost 3 billion dollars in value because of this as their stock tanked in the market. 
No comments:
Post a Comment